...
首页> 外文期刊>Nature clinical practice. Endocrinology & metabolism >Do thiazolidinediones increase the risk of congestive heart failure and cardiovascular death?
【24h】

Do thiazolidinediones increase the risk of congestive heart failure and cardiovascular death?

机译:噻唑烷二酮会增加充血性心力衰竭和心血管死亡的风险吗?

获取原文
获取原文并翻译 | 示例

摘要

The thiazolidinedione peroxisome proliferator-activated receptor y agonists are used for glycemic control in patients with type 2 diabetes mellitus. Studies have indicated, however, that these agents have a poor cardiovascular safety profile and are reportedly associated with increased fluid retention leading to congestive heart failure (CHF).
机译:噻唑烷二酮过氧化物酶体增殖物激活受体γ激动剂用于2型糖尿病患者的血糖控制。然而,研究表明,这些药物心血管安全性较差,据报道与液体滞留增加有关,导致充血性心力衰竭(CHF)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号